Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

NCT01031953 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped Drug contract timelines and inadequate enrollment

Conditions

Breakthrough Nausea and Vomiting
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: fosaprepitant dimeglumine
DRUG: systemic chemotherapy
OTHER: survey administration
PROCEDURE: quality-of-life assessment

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]